✦ LIBER ✦

Use of Subcutaneous Enoxaparin Compared to Intravenous Heparin and Oral Phenprocoumon in the Setting of Cardioversion—The ACE Study (Anticoagulation in Cardioversion Using Enoxaparin)

✍ Scribed by Christoph Stellbrink; Uwe Nixdorff; Thomas Hofmann; Walter Lehmacher; WernerGünther Daniel; Peter Hanrath; Christoph Geller; Andreas Mügge; Walter Sehnert; Caroline Schmidt-Lucke; Jan-André Schmidt-Lucke

Book ID: 114421809
Publisher: Springer
Year: 2003
Tongue: English
Weight: 71 KB
Volume: 7
Category: Article
ISSN: 1573-725X
DOI: 10.1023/b:cepr.0000023145.54503.a2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of enoxaparin compar

Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

✍ C Stellbrink; U Nixdorff; T Hofmann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety and Efficacy of Enoxaparin Compar

Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

✍ Stellbrink, C. 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 164 KB

Low molecular weight heparin for prevent

Low molecular weight heparin for prevention of thromboembolic complications in cardioversion – rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin)

✍ Stellbrink, C. ;, ;Hanrath, P. ;Nixdorff, U. ;Hofmann, T. ;Lehmacher, W. ;Kühle 📂 Article 📅 2002 🏛 Springer 🌐 German ⚖ 222 KB

Quality of anticoagulation with unfracti

Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial

✍ Caroline Schmidt-Lucke; W. Dieter Paar; Christoph Stellbrink; Uwe Nixdorff; Thom 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Trial finds that enoxaparin may be the p

Trial finds that enoxaparin may be the preferred drug for initiating anticoagulation in atrial fibrillation: Abstracted from: Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial. Circulation 2004; 109: 997-1003.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Cost in the Use of Enoxaparin Compared W

Cost in the Use of Enoxaparin Compared With Unfractionated Heparin in Patients With Atrial Fibrillation Undergoing a Transesophageal Echocardiography-Guided Cardioversion (from Assessment of Cardioversion Using Transesophageal Echocardiography [ACUTE] II Randomized Multicenter Study)

✍ Liping Zhao; Zefeng Zhang; Paul Kolm; Susan Jasper; Cheryl Lewis; Allan Klein; W 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 178 KB